Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1162)
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
16,515
Price
$91.98
Total Value
$1.52M
Shares Held After
40,272
% of Holdings
29.1%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
7,287
Price
$91.98
Total Value
$670.24K
Shares Held After
49,788
% of Holdings
12.8%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
475
Price
$9.29
Total Value
$4.41K
Shares Held After
16,525
% of Holdings
2.8%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,093
Price
$9.29
Total Value
$19.44K
Shares Held After
72,907
% of Holdings
2.8%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,770
Price
$47.30
Total Value
$131.03K
Shares Held After
288,976
% of Holdings
0.9%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
11,813
Price
$46.57
Total Value
$550.08K
Shares Held After
291,746
% of Holdings
3.9%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
894
Price
$9.29
Total Value
$8.31K
Shares Held After
32,687
% of Holdings
2.7%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
852
Price
$9.29
Total Value
$7.92K
Shares Held After
29,648
% of Holdings
2.8%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
10,349
Price
$48.26
Total Value
$499.44K
Shares Held After
245,834
% of Holdings
4.0%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
4,021
Price
$48.26
Total Value
$194.05K
Shares Held After
13,773
% of Holdings
22.6%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
5,848
Price
$48.26
Total Value
$282.22K
Shares Held After
17,794
% of Holdings
24.7%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
3,450
Price
$48.26
Total Value
$166.50K
Shares Held After
91,240
% of Holdings
3.6%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,150
Price
$48.26
Total Value
$152.02K
Shares Held After
13,143
% of Holdings
19.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$19.66
Total Value
$88.46K
Shares Held After
200,641
% of Holdings
2.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
8,000
Price
$19.66
Total Value
$157.26K
Shares Held After
205,141
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$537.37
Total Value
$85.98K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
763
Price
$536.49
Total Value
$409.34K
Shares Held After
40,673
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,551
Price
$535.59
Total Value
$830.70K
Shares Held After
41,436
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,779
Price
$534.47
Total Value
$950.82K
Shares Held After
42,987
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,526
Price
$533.65
Total Value
$1.35M
Shares Held After
44,766
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,597
Price
$532.66
Total Value
$850.66K
Shares Held After
47,292
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
564
Price
$531.69
Total Value
$299.87K
Shares Held After
48,889
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$530.73
Total Value
$106.15K
Shares Held After
49,453
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$529.16
Total Value
$190.50K
Shares Held After
49,653
% of Holdings
0.7%
Upstream Bio, Inc. (UPB)
Houghton Adam — Chief Business Officer
Shares
699
Price
$9.29
Total Value
$6.49K
Shares Held After
24,301
% of Holdings
2.8%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
1,310
Price
$63.50
Total Value
$83.19K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$63.50
Total Value
$41.53K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,610
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
595
Price
$24.99
Total Value
$14.87K
Shares Held After
675,613
% of Holdings
0.1%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
1,709
Price
$61.03
Total Value
$104.30K
Shares Held After
46,149
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$535.44
Total Value
$107.09K
Shares Held After
4,445
% of Holdings
4.3%
EyePoint, Inc. (EYPT)
Duker Jay S. — Director
Shares
1,500
Price
$13.15
Total Value
$19.72K
Shares Held After
100,665
% of Holdings
1.5%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
785
Price
$4.76
Total Value
$3.74K
Shares Held After
567,775
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
516
Price
$534.99
Total Value
$276.05K
Shares Held After
8,414
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$481.79
Total Value
$1.12M
Shares Held After
35,405
% of Holdings
6.2%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
20,000
Price
$36.04
Total Value
$720.83K
Shares Held After
38,755
% of Holdings
34.0%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
35,365
Price
$36.30
Total Value
$1.28M
Shares Held After
174,473
% of Holdings
16.9%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
16,261
Price
$38.00
Total Value
$617.92K
Shares Held After
148,397
% of Holdings
9.9%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
148
Price
$22.08
Total Value
$3.27K
Shares Held After
30,497
% of Holdings
0.5%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
2,658
Price
$21.34
Total Value
$56.72K
Shares Held After
30,645
% of Holdings
8.0%
Neurogene Inc. (NGNE)
Cobb Stuart — Chief Scientific Officer
Shares
3,991
Price
$20.41
Total Value
$81.46K
Shares Held After
33,303
% of Holdings
10.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
263
Price
$22.02
Total Value
$5.79K
Shares Held After
105,798
% of Holdings
0.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
1,395
Price
$21.25
Total Value
$29.64K
Shares Held After
106,061
% of Holdings
1.3%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
2,387
Price
$20.42
Total Value
$48.75K
Shares Held After
107,456
% of Holdings
2.2%
Stoke Therapeutics, Inc. (STOK)
LEVIN ARTHUR A — Director
Shares
605
Price
$36.80
Total Value
$22.26K
Shares Held After
4,237
% of Holdings
12.5%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,716
Price
$24.88
Total Value
$440.72K
Shares Held After
675,015
% of Holdings
2.6%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
17,717
Price
$24.88
Total Value
$440.74K
Shares Held After
675,018
% of Holdings
2.6%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
120,312
Price
$2.50
Total Value
$300.82K
Shares Held After
62,586
% of Holdings
65.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
9,759
Price
$69.23
Total Value
$675.57K
Shares Held After
4,438,447
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
10,241
Price
$68.39
Total Value
$700.35K
Shares Held After
4,448,206
% of Holdings
0.2%
Showing 301–350 of 1162 transactions (page 7 of 24)